Aerie Pharmaceuticals, Inc. To Participate In Two Investor Conferences In February

Aerie Pharmaceuticals, Inc. (Nasdaq:AERI) a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, announced today that company management will present an overview of the company at the following conferences in February.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC